Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuto Shimizu

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Oncology|December 28, 2025
Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapyMakito Miyake, Nobutaka Nishimura, Yuki Oda, et al.
Exploration of Targeted Anti-Tumor Therapy|April 20, 2026
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBCYuki Oda, Makito Miyake, Nobutaka Nishimura, et al.
IJU Case Reports|March 5, 2024
Trisomy 13 with retroiliac ureter diagnosed by assessment for recurrent febrile urinary tract infectionsYosuke Morizawa, Mitsuru Tomizawa, Takuto Shimizu, et al.
Neurochemical Research|May 27, 2021
Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture CellsTakuto Shimizu, Emiko Nogami, Yuka Ito, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 2023
[The Relationship Between Prognosis and Duration of Drug Holidays after Docetaxel Therapy for Castration-Resistant Prostate Cancer]Kenta Onishi, Nobumichi Tanaka, Yasushi Nakai, et al.
Biochimica Et Biophysica Acta. General Subjects|August 31, 2020
Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanomaTakuto Shimizu, Masaki Nagane, Mira Suzuki, et al.
Biochemical and Biophysical Research Communications|July 3, 2021
Endothelial ganglioside GM3 regulates angiogenesis in solid tumorsMira Suzuki, Masaki Nagane, Kazuhiro Kato, et al.
Cancers|April 26, 2025
5-Aminolevulinic Acid: A Novel Approach to Improving Radioresistance in Prostate CancerFumisato Maesaka, Yasushi Nakai, Takanori Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2021
Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015Yasushi Nakai, Nobumichi Tanaka, Tomomi Fujii, et al.
Japanese Journal of Clinical Oncology|December 31, 2022
The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancerNobutaka Nishimura, Makito Miyake, Tatsuki Miyamoto, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Oncology|December 28, 2025
Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapyMakito Miyake, Nobutaka Nishimura, Yuki Oda, et al.
Exploration of Targeted Anti-Tumor Therapy|April 20, 2026
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBCYuki Oda, Makito Miyake, Nobutaka Nishimura, et al.
IJU Case Reports|March 5, 2024
Trisomy 13 with retroiliac ureter diagnosed by assessment for recurrent febrile urinary tract infectionsYosuke Morizawa, Mitsuru Tomizawa, Takuto Shimizu, et al.
Neurochemical Research|May 27, 2021
Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture CellsTakuto Shimizu, Emiko Nogami, Yuka Ito, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 2023
[The Relationship Between Prognosis and Duration of Drug Holidays after Docetaxel Therapy for Castration-Resistant Prostate Cancer]Kenta Onishi, Nobumichi Tanaka, Yasushi Nakai, et al.
Biochimica Et Biophysica Acta. General Subjects|August 31, 2020
Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanomaTakuto Shimizu, Masaki Nagane, Mira Suzuki, et al.
Biochemical and Biophysical Research Communications|July 3, 2021
Endothelial ganglioside GM3 regulates angiogenesis in solid tumorsMira Suzuki, Masaki Nagane, Kazuhiro Kato, et al.
Cancers|April 26, 2025
5-Aminolevulinic Acid: A Novel Approach to Improving Radioresistance in Prostate CancerFumisato Maesaka, Yasushi Nakai, Takanori Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2021
Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015Yasushi Nakai, Nobumichi Tanaka, Tomomi Fujii, et al.
Japanese Journal of Clinical Oncology|December 31, 2022
The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancerNobutaka Nishimura, Makito Miyake, Tatsuki Miyamoto, et al.
Pageof 8